ÂÜÀòÂÒÂ×

Simon is a Senior Advisor focused on the Healthcare sector and investment opportunities in the UK. He is based in London.

He serves on the boards of Carlyle portfolio companies END., Schoen Klinic and Calastone where he is Chairman.

Prior to joining Carlyle, Mr. Dingemans was Chief Financial Officer for GlaxoSmithKline plc and a member of the main Board from 2011 to 2019 where he drove extensive restructuring and operational improvements as well as a number of significant strategic transactions. As CFO, he was responsible for leading Finance and a variety of other functions including Procurement, Real Estate as well as Technology and IT, including Cyber Security.

Before GSK, he was an investment banker for 25 years at SG Warburg and then Goldman Sachs where he was a Partner for 10 years as a leader of their European M&A business and Head of UK Investment Banking.

Mr. Dingemans served as Chairman of the Financial Reporting Council in 2019/2020.